On April 25, 2008 April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, intiated a Class I nationwide recall of Digitek® (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. (Read the full press release here).

There is a possibility that tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than it appropriate.

Digitek® is used to treat heart failure and abnormal heart rhythms.  Digitek® is used to improve the strength and efficiency of the heart, or to control the rate and rhythm of the heartbeat. This leads to better blood circulation and reduced swelling of hands and ankles in patients with heart problems.

If you or your loved one took these pills you may have experienced Digitalis toxicity which can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and Bradycardia (slow heartbeat which signals a problem if you have signs and symptoms such as fainting or shortness of breath).

Several reports of illnesses and injuries have been reported. If you believe that you were prescribed tainted Digitek® please contact our offices.